5 Key Takeaways

• 1

  The 2024 ESC Guidelines introduced a new 'elevated BP' category to identify more patients at risk for cardiovascular events.

• 2

  The guidelines recommend a new systolic BP treatment target range of 120 to 129 mmHg as the initial approach for most patients.

• 3

  Renal denervation is recommended for specific cases of resistant hypertension, but not as first-line therapy.

• 4

  The guidelines emphasize the importance of out-of-office BP measurements to support more intensive treatment targets.

• 5

  Updated dietary advice includes specific guidance on sodium and potassium intake, integrating sex and gender differences throughout.